Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine

Myelodysplastic syndromes (MDSs) represent a group of incurable stem-cell malignancies which are predominantly treated by supportive care. Epigenetic silencing through promoter methylation of a number of genes is present in poor-risk subtypes of MDS and often predicts transformation to acute myeloge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemba, Amy, Hayes, Eugene, Freeman, Burgess B., Ye, Tao, Pizzorno, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263612/
https://www.ncbi.nlm.nih.gov/pubmed/22295208
http://dx.doi.org/10.1155/2011/965826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263612/
https://www.ncbi.nlm.nih.gov/pubmed/22295208
http://dx.doi.org/10.1155/2011/965826

Ejemplares similares